Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1376)
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
54,641
Price
$101.00
Total Value
$5.52M
Shares Held After
524,938
% of Holdings
9.4%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
24,727
Price
$80.26
Total Value
$1.98M
Shares Held After
61,202
% of Holdings
28.8%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
59
Price
$101.00
Total Value
$5.96K
Shares Held After
524,938
% of Holdings
0.0%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
53,329
Price
$24.69
Total Value
$1.32M
Shares Held After
736,547
% of Holdings
7.2%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
53,329
Price
$24.69
Total Value
$1.32M
Shares Held After
736,554
% of Holdings
7.2%
Tempest Therapeutics, Inc. (TPST)
Angel Matthew — Director
Shares
231,482
Price
$2.16
Total Value
$500.00K
Shares Held After
231,482
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$536.02
Total Value
$42.88K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
536
Price
$535.39
Total Value
$286.97K
Shares Held After
40,593
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
709
Price
$534.31
Total Value
$378.83K
Shares Held After
41,129
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,890
Price
$533.21
Total Value
$1.01M
Shares Held After
41,838
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,605
Price
$532.24
Total Value
$854.24K
Shares Held After
43,728
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$530.73
Total Value
$254.75K
Shares Held After
45,333
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$529.48
Total Value
$148.26K
Shares Held After
45,813
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$528.02
Total Value
$211.21K
Shares Held After
46,093
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$526.94
Total Value
$358.32K
Shares Held After
46,493
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$525.93
Total Value
$252.45K
Shares Held After
47,173
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
256
Price
$524.62
Total Value
$134.30K
Shares Held After
47,653
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
737
Price
$523.93
Total Value
$386.13K
Shares Held After
47,909
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
527
Price
$522.89
Total Value
$275.56K
Shares Held After
48,646
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$521.85
Total Value
$208.74K
Shares Held After
49,173
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$520.75
Total Value
$62.49K
Shares Held After
49,573
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$519.10
Total Value
$145.35K
Shares Held After
49,693
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$516.84
Total Value
$20.67K
Shares Held After
49,973
% of Holdings
0.1%
MeiraGTx Holdings plc (MGTX)
Forbes Alexandria — Director
Shares
62,000
Price
$7.41
Total Value
$459.42K
Shares Held After
1,449,695
% of Holdings
4.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$72.00
Total Value
$360.00K
Shares Held After
15,000
% of Holdings
33.3%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
34,665
Price
$72.00
Total Value
$2.50M
Shares Held After
485,000
% of Holdings
7.1%
IMPACT BIOMEDICAL INC. (IBO)
Grady Jason — Director
Shares
50,000
Price
$0.65
Total Value
$32.51K
Shares Held After
250,182
% of Holdings
16.7%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
7,611
Price
$24.90
Total Value
$189.51K
Shares Held After
683,218
% of Holdings
1.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
7,612
Price
$24.90
Total Value
$189.54K
Shares Held After
683,225
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,200
Price
$80.05
Total Value
$96.06K
Shares Held After
61,202
% of Holdings
1.9%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
6,105
Price
$79.87
Total Value
$487.61K
Shares Held After
62,402
% of Holdings
8.9%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
8,214
Price
$78.40
Total Value
$643.95K
Shares Held After
68,507
% of Holdings
10.7%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
52,975
Price
$77.21
Total Value
$4.09M
Shares Held After
76,721
% of Holdings
40.8%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
22,756
Price
$76.73
Total Value
$1.75M
Shares Held After
129,696
% of Holdings
14.9%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
1,875
Price
$45.53
Total Value
$85.37K
Shares Held After
43,886
% of Holdings
4.1%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
32,916
Price
$45.53
Total Value
$1.50M
Shares Held After
65,832
% of Holdings
33.3%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.25
Total Value
$130.00K
Shares Held After
906,556
% of Holdings
4.2%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
17,000
Price
$36.81
Total Value
$625.82K
Shares Held After
187,640
% of Holdings
8.3%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
1,314
Price
$36.48
Total Value
$47.93K
Shares Held After
187,640
% of Holdings
0.7%
Vericel Corp (VCEL)
Hagen Heidi — Director
Shares
15,000
Price
$32.41
Total Value
$486.15K
Shares Held After
31,850
% of Holdings
32.0%
LIGAND PHARMACEUTICALS INC (LGND)
Sabba Stephen L — Director
Shares
1,000
Price
$207.87
Total Value
$207.87K
Shares Held After
32,793
% of Holdings
3.0%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
9,200
Price
$18.52
Total Value
$170.35K
Shares Held After
145,355
% of Holdings
6.0%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
6,500
Price
$2.86
Total Value
$18.57K
Shares Held After
0
% of Holdings
100.0%
OnKure Therapeutics, Inc. (OKUR)
Saccomano Nicholas A — Director
Shares
86
Price
$4.16
Total Value
$357.46
Shares Held After
7,333
% of Holdings
1.2%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
12,149
Price
$0.83
Total Value
$10.04K
Shares Held After
3,859,847
% of Holdings
0.3%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
4,422
Price
$0.83
Total Value
$3.66K
Shares Held After
1,807,345
% of Holdings
0.2%
Quantum-Si Inc (QSI)
LaPointe Christian — GC & Corp. Secretary
Shares
6,110
Price
$0.83
Total Value
$5.05K
Shares Held After
1,198,017
% of Holdings
0.5%
Quantum-Si Inc (QSI)
Vieceli John S. — Chief Product Officer
Shares
11,239
Price
$0.83
Total Value
$9.29K
Shares Held After
1,170,657
% of Holdings
1.0%
OnKure Therapeutics, Inc. (OKUR)
Leverone Jason A. — Chief Financial Officer
Shares
301
Price
$4.16
Total Value
$1.25K
Shares Held After
16,000
% of Holdings
1.8%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
10,020
Price
$46.78
Total Value
$468.74K
Shares Held After
255,501
% of Holdings
3.8%
Showing 1–50 of 1376 transactions (page 1 of 28)